by Extivita | Mar 14, 2012 | Cancer
Abstract: In our randomized trial on hyperbaric oxygen (HBO), it was shown that HBO could reduce dysphagia and xerostomia, which are frequently encountered after (chemo-) radiotherapy (RT) and/or surgery for head and neck cancer (HNC). A risk model and nomogram are...
by Extivita | Jul 24, 2008 | Carcinoma
Abstract: Comparison of quality of life (QoL) and side effects in a randomized trial for early hyperbaric oxygen therapy (HBOT) after radiotherapy (RT). From 2006, 19 patients with tumor originating from the tonsillar fossa and/or soft palate (15), base of tongue (1),...
by Extivita | Apr 17, 2007 | Carcinoma
Abstract: Radiotherapy is used in the setting of curative treatment for head and neck cancer. Xerostomia and related problems occur when major salivary glands are included in the irradiation fields. This reduces quality of life (QOL). Hyperbaric oxygen therapy (HBOT)...
by Extivita | Jul 9, 2004 | Cancer
Abstract: Sophisticated endoscopical palliation in end-stage malignant stenosis of the esophagus and gastroesophageal-junction must be weighed against associated morbidity and mortality. In a prospective study we investigated benefits and risks of one type of coated,...
by Extivita | Apr 24, 1999 | Cancer
Abstract: Stenting is a well established palliative treatment for stenotic malignant disease of the esophagus. Because of its merely mechanical potential other tumoricidal techniques are often done before stenting. We did esophageal stenting in 11 patients (9 men and...
